11月20日，鸿泉技术盘中下跌2.05%，截至10:07，报27.28元/股，成交3321.66万元，换手率1.19%，总 市值27.23亿元。 截至9月30日，鸿泉技术股东户数5530.00，较上期减少7.88%；人均流通股18049股，较上期增加 7.66%。2025年1月-9月，鸿泉技术实现营业收入4.95亿元，同比增长35.85%；归母净利润4105.82万元， 同比增长237.08%。 分红方面，鸿泉技术A股上市后累计派现6500.00万元。近三年，累计派现0.00元。 责任编辑：小浪快报 今年以来鸿泉技术已经2次登上龙虎榜，最近一次登上龙虎榜为3月12日。 资料显示，杭州鸿泉物联网技术股份有限公司位于浙江省杭州市滨江区西兴街道启智街35号，成立日期 2009年6月11日，上市日期2019年11月6日，公司主营业务涉及利用大数据、人工智能及5G等前沿技术, 研发、生产和销售汽车智能网联设备及大数据云平台等产品。主营业务收入构成为：智能网联 54.66%，智能座舱19.26%，控制器13.57%，软件平台开发12.07%，其他0.44%。 鸿泉技术所属申万行业为：计算机-计算机设备-其他计算机设备。所 ...

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Core Insights - On November 18, several companies disclosed their shareholding changes, with 康缘药业, 超达装备, and 海大集团 announcing share buybacks, while 15 companies, including 立达信 and 艾布鲁, reported share reductions [1][2]. Group 1: Share Buybacks - 康缘药业's actual controller and director, 肖伟, increased his shareholding by 20,000 shares [2]. - 超达装备 secured a stock repurchase loan commitment from China Bank for up to 450 million yuan [2]. - 海大集团 plans to repurchase shares worth no less than 1 billion yuan and up to 1.6 billion yuan [2]. Group 2: Share Reductions - 立达信's shareholder, 李春华, intends to reduce his stake by no more than 1.56% [2]. - 艾布鲁's controlling shareholder, 钟儒波, plans to reduce his stake by no more than 3% [2]. - 高德红外's actual controller, 黄立, aims to reduce his stake by no more than 3% [2]. - 嘉美包装's shareholders plan to collectively reduce their stake by no more than 1.16% [2]. - 蓄奥规划's shareholders intend to reduce their stake by no more than 1% [2]. - 君逸数码's shareholder, 成都高创投, plans to reduce his stake by no more than 1% [2]. - 联合水务's shareholder, 上海衡联, intends to reduce his stake by no more than 0.14% [2]. - 亚翔集成's second-largest shareholder has reduced 130,000 shares and is still in the reduction period [2]. - 芯朋微's controlling shareholder, 张立新, has terminated his reduction plan early [2]. - 安旭生物's shareholder, 马华祥, plans to reduce his stake by no more than 0.94% [2]. - 农心科技's shareholder, 宁波农旗, intends to reduce his stake by no more than 0.54% [2]. - 禾川科技's actual controller and others plan to reduce their stake by no more than 6% [2]. - 世龙实业's shareholder, 电化高科, plans to reduce his stake by no more than 3% [2]. - 中国化学's executive, 聂宁新, intends to reduce his stake by no more than 60,000 shares [2]. - 鸿泉技术's shareholder, 千方科技, plans to reduce his stake by no more than 3% [2].

鸿泉技术11月18日晚间公告，公司持股5%以上股东北京千方科技因自身资金需求，计划自2025年12月 10日起至2026年3月9日止，通过集中竞价和大宗交易方式减持公司股份不超过299.44万股，即不超过公 司总股本的3%。其中，通过集中竞价方式减持不超过99.81万股，通过大宗交易方式减持不超过199.63 万股。减持价格将根据减持时的市场价格确定。本次减持计划实施具有不确定性。 ...

证券日报网讯 11月18日晚间，鸿泉技术发布公告称，北京千方科技股份有限公司（以下简称千方科 技）持有杭州鸿泉物联网技术股份有限公司（以下简称鸿泉技术或公司）股份共计11，921，054股，占 公司目前总股本的比例为11.94%。因自身资金安排，千方科技计划通过集中竞价、大宗交易的方式， 合计减持不超过其持有公司股份2，994，411股，即不超过公司总股本的3.00%。 （文章来源：证券日报） ...

Group 1 - Hongquan Technology announced that Beijing Qianfang Technology Co., Ltd. holds approximately 11.94% of its total shares, equating to about 11.92 million shares [1] - Qianfang Technology plans to reduce its holdings by up to 3% of the total shares, which is approximately 2.99 million shares, through centralized bidding and block trading [1] - The reduction plan will take place within three months after the announcement, with specific limits on the number of shares that can be sold in any 90-day period [1] Group 2 - For the year 2024, Hongquan Technology's revenue composition is projected to be 96.81% from the Internet of Things (IoT) and 3.19% from other businesses [1] - The current market capitalization of Hongquan Technology is reported to be 3 billion yuan [2]

智通财经APP讯，鸿泉技术(688288.SH)公告，公司股东千方科技计划通过集中竞价、大宗交易的方 式，合计减持不超过其持有公司股份299.44万股，即不超过公司总股本的3.00%。 ...

鸿泉技术(688288.SH)公告，公司股东千方科技（002373）计划通过集中竞价、大宗交易的方式，合计 减持不超过其持有公司股份299.44万股，即不超过公司总股本的3.00%。 ...

人民财讯11月18日电，鸿泉技术(688288)11月18日公告，股东北京千方科技（002373）股份有限公司(简 称"千方科技")持有公司11.94%股份，计划通过集中竞价、大宗交易的方式，合计减持不超过其持有公 司股份299.44万股，即不超过公司总股本的3%。 ...

杭州鸿泉物联网技术股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 北京千方科技股份有限公司（以下简称千方科技）持有杭州鸿泉物联网技术 股份有限公司（以下简称鸿泉技术或公司）股份共计 11,921,054 股，占公司目 前总股本的比例为 11.94%。前述股份均为无限售流通股，自同一实际控制人控 制的北京北大千方科技有限公司 IPO 前取得并通过协议转让方式受让所得。 减持计划的主要内容 因自身资金安排，千方科技计划通过集中竞价、大宗交易的方式，合计减持 不超过其持有公司股份 2,994,411 股，即不超过公司总股本的 3.00%。 本次减持计划期间，采用集中竞价方式减持的，自本公告披露之日起 15 个 交易日后的 3 个月内进行，且在任意连续 90 个自然日内，减持公司股份的总数 不超过公司总股本的 1%（即不超过 998,137 股）；采用大宗交易方式减持的，自 本公告披露之日起 15 个交易日后的 3 个月内进行， ...